Maxence Abasq
About Maxence Abasq
Maxence Abasq is a Therapy Representative Complex PCI at Boston Scientific in France. He has a background in biomedical and general engineering, with experience in research and partnership management.
Title
Maxence Abasq holds the position of Therapy Representative Complex PCI at Boston Scientific.
Currently Working at Boston Scientific
Maxence Abasq has been serving as a Therapy Representative Complex PCI at Boston Scientific since 2021. In this role, he is involved in specialized therapies targeting complex percutaneous coronary intervention (PCI) procedures in France.
Past Experience at Boston Scientific
Previously, Maxence was part of the New Cardio Graduate Foundation Program at Boston Scientific from 2020 to 2021. Based in the Greater Paris Metropolitan Region, he gained specialized training in cardiovascular therapies during his 6-month tenure with the program.
Educational Background
Maxence Abasq earned a Master of Engineering (MEng) in Génie Biomédical from Polytechnique Montréal, where he studied from 2018 to 2020. Prior to that, he achieved a Diplôme d'ingénieur in Ingénieur généraliste from Ecole Centrale de Marseille, studying there from 2016 to 2020. He also completed preparatory classes (Classes Préparatoires aux Grandes Ecoles - PCSI/PC*) and his Baccalauréat Scientifique at Lycée Lapérouse-Kérichen from 2010 to 2016.
Research and Internship Experience
In 2020, Maxence completed a final year project at Polytechnique Montréal focusing on a specific area of biomedical engineering. In 2018, he gained research experience as a research assistant intern at CIML in Marseille. Additionally, he completed an internship at La Table de Cana Marseille in 2017.
Professional Involvement in Student Organizations
Maxence served as Responsable des partenariats at the Bureau des Sports - École Centrale de Marseille from 2016 to 2018, where he was responsible for managing partnerships. He was also an active member of the Forum Centrale Marseille Entreprises (FOCEEN) from 2016 to 2017.